trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


New VISMED® GEL MULTI available! - High protection, anytime, anywhere

pack_vismed_gel_multi_rgb_72dpi_kombi.jpg

 

Now available VISMED® GEL MULTI has the same hypotonic and non-preserved formulation as VISMED® GEL with 0.3% hyaluronic acid and essential ions but presented in the preservative-free multidose dispenser.

This special delivery system allows VISMED® GEL MULTI to remain sterile and free from contamination for up to 3 months after opening. Its ergonomic and intuitive delivery system, 10 ml content and compact size design make it the perfect solution for a long lasting relief of more severe dry eye conditions.

Always at hand…high protection, anytime, anywhere.


ostenil_plus.png

Mannitol-stabilised high dose HA for sustained effect

OSTENIL® PLUS is a unique combination of natural high dose HA (2%) + mannitol.

Mannitol acts as a free radical scavenger which protects HA from rapid depolymerisation.

The formulation offers the possibility of reducing the number of intra-articular injections and increasing the intervals between injections. 

OSTENIL® PLUS reduces pain and improves function in osteoarthritis with very good tolerability.

Effective treatment with 1 to 3 injections of OSTENIL® PLUS

ostenil_plus.jpg
This new packaging design may not yet be available in your country 


pdf OSTENIL® PLUS Brochure
pdf OSTENIL® Line Brochure
pdf OSTENIL® PLUS instructions for use
Distributors
trb_contact.gifContacts

News-Events
 
 
  • English